CHAMPIONS ONCOLOGY, INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31)
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) of -$57.00 thousand for the 12-month period ending 2012-04-30, per its 10-K filed 2012-07-18.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTax · last filed 2012-07-18
- CHAMPIONS ONCOLOGY, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for fiscal 2012 was -$57.00K.
- CHAMPIONS ONCOLOGY, INC. other comprehensive income (loss), foreign currency translation adjustment, tax (deprecated 2012-01-31) for fiscal 2011 was -$64.00K.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax (Deprecated 2012-01-31) 12 month |
|---|---|
| 2012-04-30 | -$57.00K 10-K · filed 2012-07-18 |
| 2011-04-30 | -$64.00K 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |